Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 250 participants.

Also called NCT02777593

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02777593
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02777593. Non-randomized; no masking; primary purpose treatment. Start 2016-09-06 (actual); primary completion 2021-04-12 (actual). Results posted on 2022-11-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
Acronym
SSB 11-02
Condition
Aortic Aneurysm, Thoracic
Condition
Aorta; Lesion
Intervention (Device)
GORE® TAG® Thoracic Branch Endoprosthesis
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct02777593
Content hash
3053c7e4c802eef7aff50ee47bfeafc406d6b6e55c4a56953a0ff6b4fc7bb324